HKG Equity Snapshot
6978 Weekly Equity Report
Immunotech Biopharm Ltd
What the company does
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. The company's core product is EAL, a multi-target cellular immunotherapy product that has completed Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia that is in Phase II/III clinical trial; 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; RC19D2 for relapsed and refractory diffuse large …
What the weekly tape is saying
6978 closed the latest completed week at 0.61 HKD. The 4-week return is -30.7% and the 12-week return is -76.0%. Trend Signal is inactive, Market Dynamics is -1.16. Setup signature: Risk-first tape with a 6/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 2.34 HKD
- Vs Trend Line
- -73.9%
- Fair Value
- 3.33 HKD
- Vs Fair Value
- -81.7%
- 52W High
- 5.83 HKD
- 52W Low
- 0.54 HKD
- Drawdown
- -89.5%
- Range Position
- 1.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 13
- 52W Active Breadth
- 25.0%
- Sector Scope
- HK Healthcare
- Sector Rank
- 249 of 257
- Sector Percentile
- 3.1%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 66 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.16
- 4W MD Change
- -343.4%
- Relative Strength
- -79.10
- 4W RS Change
- -8.1%
- Expectation
- Undecided
- Probability
- 47.24%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 3.5M
- 13W Average
- 6.5M
- 52W Average
- 5.0M
- Vs 13W
- 0.5x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 20.1%
- 52W Volatility
- 13.1%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 6.8% / -9.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 444.6M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.61 HKD | -14.1% | 2.34 HKD | 3.33 HKD | -1.16 | -79.10 | 3.5M | Off |
| 5 Jun 2026 | 0.71 HKD | -9.0% | 2.42 HKD | 3.35 HKD | -1.17 | -76.31 | 1.8M | Off |
| 29 May 2026 | 0.78 HKD | -1.3% | 2.51 HKD | 3.38 HKD | -1.04 | -74.62 | 1.9M | Off |
| 22 May 2026 | 0.79 HKD | -10.2% | 2.59 HKD | 3.40 HKD | -0.78 | -75.11 | 3.6M | Off |
| 15 May 2026 | 0.88 HKD | 1.1% | 2.67 HKD | 3.42 HKD | -0.26 | -73.16 | 7.0M | Off |
| 8 May 2026 | 0.87 HKD | -16.3% | 2.75 HKD | 3.44 HKD | 0.39 | -74.35 | 17.2M | Off |
| 1 May 2026 | 1.04 HKD | -64.7% | 2.87 HKD | 3.46 HKD | 0.93 | -69.18 | 35.5M | Off |
| 24 Apr 2026 | 2.95 HKD | -13.0% | 2.98 HKD | 3.47 HKD | 1.10 | -14.93 | 1.7M | Off |
| 17 Apr 2026 | 3.39 HKD | -3.1% | 3.02 HKD | 3.48 HKD | 1.06 | -3.97 | 4.7M | Off |
| 10 Apr 2026 | 3.50 HKD | 28.7% | 3.07 HKD | 3.48 HKD | 0.66 | -0.71 | 4.5M | Off |
| 3 Apr 2026 | 2.72 HKD | -2.2% | 3.11 HKD | 3.49 HKD | 0.25 | -21.05 | 558.9K | Off |
| 27 Mar 2026 | 2.78 HKD | 9.4% | 3.20 HKD | 3.50 HKD | -0.01 | -19.44 | 1.8M | Off |
| 20 Mar 2026 | 2.54 HKD | -0.4% | 3.28 HKD | 3.51 HKD | -0.22 | -27.80 | 660.8K | Off |
| 13 Mar 2026 | 2.55 HKD | 8.5% | 3.35 HKD | 3.53 HKD | -0.33 | -28.82 | 1.7M | Off |